TMO continues to capture investors' attention due to its innovative product launches and trusted partnership status.

Roche plans to release the system in the US to run tests including vitamin D and steroid assays under CLIA before it possibly receives US Food and Drug Administration clearance.

After revenue boomed for biopharma manufacturers during the COVID pandemic, sales have stagnated for several CDMO giants, ...

Telops Radia Family is designed as an accessible entry point into the world of scientific IR imaging. With cooled and ...

Thermo Fisher Scientific Inc (TMO) stock saw a modest uptick, ending the day at $573.06 which represents a slight increase of $13.41 or 2.40% from the prior close of $559.65. The stock opened at $563 ...